https://www.inspiredhygiene.com/feed&follow=1
-
![]()
White House, facing pressure from activists, to accelerate rollout of monkeypox treatments and vaccinesBiden administration health officials said Wednesday they would accelerate access to vaccines and treatments for monkeypox , as the White House...
-
![]()
Akili’s deal to go public via SPAC could close soonYou’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
![]()
Opinion: Genetic research provides new clarity about the ‘whys’ of autismIt was an appropriately hazy afternoon on the day my son Dylan, age two years, seven months, and sixteen days, was diagnosed with autism. The...
-
![]()
STAT+: ‘We’re finally here’: Harvard graduate spearheads custom gene therapy for younger brotherRichard Horgan has waited for this moment for more than three years. Last month, the Food and Drug Administration granted permission for his...
-
![]()
STAT+: Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisisHello, everyone, and how are you today? We are doing just fine, thank you, courtesy of clear blue skies and cool breezes circling about the...
-
![]()
Opinion: Organ transplantation is at a crossroads. Major reform is neededIn early August, the Senate Finance Committee held a bipartisan hearing co-chaired by Senators Ron Wyden (D-Ore.) and Charles Grassley (R-Iowa)...
-
![]()
STAT+: Pharma’s likely to sue over Medicare negotiation. Here are the arguments they might useWASHINGTON — Democrats finally achieved a win over the pharmaceutical industry this month when they passed the most aggressive drug pricing...
-
![]()
Opinion: History doesn’t have to repeat itself with stigma and monkeypoxRicky (not his real name), is a patient of mine: a young, gay man with a gentle soul and well-controlled HIV. He recently went to his local...
-
![]()
Biden administration has simple way to cut overdose deaths, experts say: expand methadone accessWASHINGTON — When it comes to fighting opioid addiction, there’s no tool more effective than methadone. Doctors have been...
-
![]()
Risk of ‘brain fog’ and other conditions persists up to two years after Covid infectionAmong the many worrying consequences of Covid-19, neuropsychiatric conditions rank high. A year ago researchers from Oxford University reported...
-
![]()
Judge rules CVS, Walgreens, and Walmart owe $650M in opioids suitCLEVELAND — A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against...
-
![]()
STAT+: Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorderThe Food and Drug Administration on Wednesday approved a new treatment that delivers a potentially permanent, genetic fix for patients with the...
-
![]()
In an effort to address its missteps during Covid, CDC plans an ‘ambitious’ agency overhaulThe Centers for Disease Control and Prevention, an agency that has had its reputation battered by a series of missteps in the Covid-19 pandemic,...
-
![]()
STAT+: ‘A blind eye’: NIH fails to ensure clinical trial results are reported, and still funds researchers who don’t file resultsThe U.S. National Institutes of Health failed to ensure that results of roughly half of clinical trials funded by the agency — both those...
-
![]()
Virtual Event – Biomarkers: The Foundation of Personalized OncologyEditor’s note: A recording of this conversation is embedded below. Cancer biomarkers can help predict whether therapies will work in...
-
![]()
STAT+: Pharmalittle: Endo files for bankruptcy protection due to opioid suits; first Zantac lawsuit dropped, giving GSK a boostGood morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days...
-
![]()
STAT+: Blueprint Medicines drug reduces mastocytosis symptoms in a new study, meeting investor expectationsA drug made by Blueprint Medicines markedly improved symptoms of a rare immune system disorder called non-advanced systemic mastocytosis in a...
-
![]()
STAT+: Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investmentsInnovation Endeavors, the venture capital firm co-founded by former Google chairman and CEO Eric Schmidt, is bringing in one of the few...
-
![]()
STAT+: Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study findsHospitals that merge under state regulations that shield them from federal scrutiny tend to eventually break free of those controls and raise...
-
![]()
Opinion: Medical error: An epidemic compounded by gag lawsCovid-19 turned hospitals into battlefields. Wards burst at the seams, caregivers died in the thousands, staff burnout and compassion fatigue...
-
![]()
STAT+: Frustrated with nature’s biomarkers for cancer, biologists try making their ownOn Target is a recurring feature from STAT that dives deep into the most promising drug targets in oncology. The hunt for cancer...
-
![]()
As the Smithsonian wraps a landmark genome exhibit, leaders in the field reflect on what’s changedWhen the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary...
-
![]()
STAT+: Cepheid faces fresh criticism over the pricing of its TB diagnosticsA controversy has broken out over a diagnostic for tuberculosis that, until recently, had been subsidized by the World Health Organization...
-
![]()
Brewing data battles, One Medical’s dueling offers, and monkeypox bottleneckYou’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this...
-
![]()
Over-the-counter hearing aids expected this fall in U.S.Millions of Americans will be able to buy hearing aids without a prescription later this fall, under a long-awaited rule finalized Tuesday. The...
